Prevention and treatment strategies for type 2 diabetes based on regulating intestinal flora

被引:16
|
作者
Xie, Dandan [1 ]
Zhao, Xiaotong [1 ]
Chen, Mingwei [1 ]
机构
[1] Anhui Med Univ, Dept Endocrinol, Affiliated Hosp 1, 218 Jixi Rd, Hefei 230032, Anhui, Peoples R China
关键词
type 2 diabetes mellitus; intestinal microbiota; insulin resistance; research progress; GUT MICROBIOTA; BARIATRIC SURGERY; INSULIN SENSITIVITY; METFORMIN TREATMENT; GLUCOSE; BIFIDOBACTERIA; METABOLISM; INCREASES; IMPACT;
D O I
10.5582/bst.2021.01275
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Diabetes along with related comorbidities associated with high disability rates severely threatens human health. The etiology of diabetes is complex. Genetics, environmental factors, eating habits, drug usage, aging, and lack of movement play important roles in the development of diabetes. Intestinal flora is reportedly closely related to the occurrence and development of type 2 diabetes. Herein, we review changes in abundance and proportion of intestinal flora in patients with type 2 diabetes and regulation of intestinal flora through diet, drugs, and surgery to prevent and treat type 2 diabetes. A more appropriate clinical diagnosis and treatment plan could be made considering changes in intestinal flora in the future.
引用
收藏
页码:313 / 320
页数:8
相关论文
共 50 条
  • [41] Sedentary behaviour as a new behavioural target in the prevention and treatment of type 2 diabetes
    Henson, Joseph
    Dunstan, David W.
    Davies, Melanie J.
    Yates, Thomas
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2016, 32 : 213 - 220
  • [42] Prevention and management of type 2 diabetes: dietary components and nutritional strategies
    Ley, Sylvia H.
    Hamdy, Osama
    Mohan, Viswanathan
    Hu, Frank B.
    LANCET, 2014, 383 (9933) : 1999 - 2007
  • [43] Composite probiotics alleviate type 2 diabetes by regulating intestinal microbiota and inducing GLP-1 secretion in db/db mice
    Wang, Yanming
    Dilidaxi, Dinareer
    Wu, Yuche
    Sailike, Jialehasibieke
    Sun, Xin
    Nabi, Xin-hua
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 125
  • [44] Type 2 Diabetes Treatment in the Patient with Obesity
    Malin, Steven K.
    Kashyap, Sangeeta R.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2016, 45 (03) : 553 - +
  • [45] Research progress of traditional Chinese medicine regulating intestinal flora in the treatment of hypertension
    Chen, Wenjun
    Xiao, Longfei
    Guo, Wenlong
    Li, Hailin
    Chen, Rong
    Duan, Zhongyu
    Chen, Qinghua
    Lei, Qing
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [46] Review Article Nourishing Yin traditional Chinese medicine: potential role in the prevention and treatment of type 2 diabetes
    Dai, Yu -Ping
    Duan, Yan
    Ni, Xiao-Ting
    Zhang, Yun-Kun
    Li, Juan
    Li, Shun-Xiang
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (01): : 234 - 254
  • [47] Trending Modalities in Type 2 Diabetes Prevention
    Lundgrin, Erika L.
    Hatipoglu, Betul
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2025, 110 : S187 - S192
  • [48] 4-Hydroxyisoleucine: A Potential New Treatment for Type 2 Diabetes Mellitus
    Zafar, Mohammad Ishraq
    Gao, Feng
    BIODRUGS, 2016, 30 (04) : 255 - 262
  • [49] Diet and gut microbiome: Impact of each factor and mutual interactions on prevention and treatment of type 1, type 2, and gestational diabetes mellitus
    Menafra, Davide
    Progano, Mattia
    Tecce, Nicola
    Pivonello, Rosario
    Colao, Annamaria
    HUMAN NUTRITION & METABOLISM, 2024, 38
  • [50] Will intestinal flora therapy become a new target in type-2 diabetes mellitus? A review based on 13 clinical trials
    Wang, Fujie
    Zhao, Ting
    Wang, Weiwei
    Dai, Qianqian
    Ma, Xianghua
    NUTRICION HOSPITALARIA, 2022, 39 (02) : 425 - 433